Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Pathology and Forensic Medicine
Link
http://link.springer.com/content/pdf/10.1007/s12022-020-09609-2.pdf
Reference27 articles.
1. Colao A, Grasso LF, Pivonello R, Lombardi G.: Therapy of aggressive pituitary tumors. Expert Opin Pharmaco. 12:1561–1570 (2011)
2. Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, de Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wémeau JL, de Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A: Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91: 3316–3323 (2006)
3. Theodros D, Patel M, Ruzevick J, Lim M, Bettegowda C.: Pituitary adenomas: historical perspective, surgical management and future directions. CNS Oncol. 4(6):411–429 (2015)
4. Mete O, Lopes MB. Overview of the 2017 WHO Classification of Pituitary Tumors. Endocr Pathol Sep;28(3):228–243 (2017)
5. Inoshita N, Nishioka H.: The 2017 WHO classification of pituitary adenoma: overview and comments. Brain Tumor Pathol. Apr;35(2):51–56 (2018)
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors;Brain Pathology;2024-09
2. Grading and staging for pituitary neuroendocrine tumors;Brain Pathology;2024-08-25
3. Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas;Frontiers in Endocrinology;2023-07-17
4. Gamma knife radiosurgery for high-risk lactotroph adenomas: Long-term results;Journal of Clinical Neuroscience;2021-04
5. Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?;Endocrine Pathology;2021-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3